Valtoco Spray
Product Images NDC 72252-510

Product Visual Gallery

This gallery contains 19 technical images submitted to the FDA as part of the official labeling for Valtoco (NDC 72252-510). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Neurelis, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Valtoco 01)

Chemical structure diagram of diazepam, the active ingredient in Valtoco nasal spray. The structure shows a benzodiazepine core with a chlorophenyl group, a methyl group attached to a nitrogen atom, and a benzene ring.*

FDA Label Image

Figure 1 (Valtoco 02)

A horizontal bar graph comparing the percentage of patients reporting outcomes (better, same, worse) for Diazepam Rectal Gel and Placebo. Diazepam Rectal Gel shows a higher percentage of patients reporting better outcomes (82%) compared to Placebo (33%). The graph uses three categories indicated by different fill patterns: solid black for better, diagonal stripes for same, and empty for worse.*

FDA Label Image

Figure 2 (Valtoco 03)

A line graph showing the probability of no seizure over a 24-hour period comparing diazepam rectal gel and placebo. The Y-axis represents the probability of no seizure (0 to 1), and the X-axis shows time in hours (0 to 24). The diazepam rectal gel line remains consistently higher than placebo, indicating a greater probability of no seizure over time.*

FDA Label Image

Figure 3 (Valtoco 04)

A Kaplan-Meier curve comparing the probability of no seizure over time (hours) between Diazepam Rectal Gel and placebo groups. The y-axis shows the probability of no seizure, and the x-axis shows time in hours, illustrating the differences in seizure-free probabilities between treatments over a 12-hour period.*

FDA Label Image

Figure (Valtoco 05)

Valtoco nasal spray device. The image shows a white plastic nasal spray applicator with a nozzle and a protective cover, designed for delivering diazepam in the nasal route. No specific strength or label text is visible on the device in the image.*

FDA Label Image

Figure (Valtoco 06)

An instructional illustration showing hands removing a prefilled nasal spray device, labeled Valtoco, from a sealed plastic blister package. The device is intended for nasal administration and contains diazepam.*

FDA Label Image

Figure (Valtoco 07)

An instructional diagram showing how to hold the Valtoco nasal spray device, highlighting the nozzle and plunger components for proper usage.*

FDA Label Image

Figure (Valtoco 08)

An instructional illustration showing a person using the Valtoco nasal spray by inserting the spray nozzle into the nostril and activating the spray. The image demonstrates proper administration technique for the nasal spray dosage form.*

FDA Label Image

Figure (Valtoco 09)

An instructional illustration showing the proper use of Valtoco nasal spray. It depicts a hand holding the nasal spray device close to the nose, demonstrating administration by spraying into one nostril.*

FDA Label Image

Figure (Valtoco 10)

An illustration showing a white plastic nasal spray device with two spray nozzles side-by-side. The image depicts a dispenser mechanism likely used for administering nasal spray medication, consistent with the nasal spray dosage form of Valtoco (diazepam).*

FDA Label Image

Figure (Valtoco 11)

An instructional illustration showing hands holding and opening a blister pack containing a nasal spray device. The image suggests how to remove the spray from its packaging, related to the Valtoco diazepam nasal spray.*

FDA Label Image

Figure (Valtoco 12)

An instructional diagram showing the proper handling of the Valtoco nasal spray device. It depicts a hand holding the device with labeled parts: the nozzle and the plunger, illustrating the method to position fingers for use.*

FDA Label Image

Figure (Valtoco 13)

An instructional illustration showing a person using a nasal spray, with the spray device positioned at the nostril and a finger pressing on the spray actuator. The image demonstrates the proper nasal administration technique for a nasal spray product.*

FDA Label Image

Figure (Valtoco 14)

An instructional illustration showing a hand holding a nasal spray device aimed at a person's nostril. The diagram depicts the correct administration technique for administering a nasal spray, corresponding to Valtoco (diazepam) nasal spray usage.*

FDA Label Image

Figure (Valtoco 15)

An instructional illustration showing a person's hand removing a nasal spray device from a molded tray packaging, emphasizing handling or preparation steps for use.*

FDA Label Image

Principal Display Panel (5 mg Device Blister Pack Carton)

Valtoco 5 mg diazepam nasal spray carton packaging. The box indicates nasal use only, with each blister pack containing one nasal spray device delivering a 5 mg dose. Manufactured by Neurelis, Inc., it includes warnings, pharmacist instructions, storage information, inactive ingredients, and a barcode. The packaging is white with silver and green accents and features the Valtoco logo prominently.*

FDA Label Image

Principal Display Panel (15 mg Device Blister Pack Carton)

Packaging label for Valtoco 15 mg (diazepam nasal spray) by Neurelis, Inc. The label shows the product is for nasal use only and contains 2 blister packs, each with 2 nasal spray devices providing 1 dose of 15 mg total. It includes warnings, storage instructions, and pharmacist dispensing information. The label also lists inactive ingredients and contact details for more product information.*

FDA Label Image

Principal Display Panel (10 mg Device Blister Pack Carton)

Label and carton design for Valtoco (diazepam nasal spray) 10 mg by Neurelis, Inc. Includes warnings to use nasal spray only once per device and to avoid opening or testing sprays before use. Box contains 2 blister packs, each with one nasal spray delivering 10 mg diazepam in 0.1 mL solution. Storage, handling, and pharmacist dispensing instructions are provided. Barcode and inactive ingredients listed.*

FDA Label Image

Principal Display Panel (20 mg Device Blister Pack Carton)

Valtoco 20 mg (diazepam nasal spray) carton label shows a 2-pack of nasal spray devices, each delivering 10 mg diazepam per 0.1 mL. The label emphasizes nasal use only and that devices spray one time only. Manufacturer Neurelis, Inc is identified along with usage warnings and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.